Medical News
Vegan Mom Who Fed 11-Month-Old Baby Nuts And Berries Charged For Child Endangerment
Tech Times - 8 Oct 2016 04:56
A mother was charged of child endangerment for feeding her 11-month-old son only nuts and berries. The child suffered from malnutrition, developmental delays and rashes.
Damian Marley, Entrepreneur: Bob Marley's Youngest Son Converting A Former California Prison Into A Pot Farm
Tech Times - 8 Oct 2016 18:22
Damian Marley bought an old prison in the state of California with the aim of turning it into a facility for growing medical cannabis. If the state's Proposition 64 passes, the company will also be able to sell marijuana...
'Executioner' Protein Responsible For Brain Cell Death In Strokes, Alzheimer's Disease
Tech Times - 8 Oct 2016 17:05
A new study discovered the protein responsible for cell death in almost all cases of cell injury. The mechanisms of the macrophage migration inhibitory factor in contact with the mitochondrial apoptosis-inducing factor p...
Mylan To Pay $465 Million Over EpiPen Medicaid Rebate Classification
Tech Times - 8 Oct 2016 07:47
Mylan has agreed to pay $465 million after lawmakers and health officials said it wrongly classified EpiPen as a generic product. The classification allowed the pharmaceutical company to pay lower rebates for Medicaid pr...
Ribociclib improves progression-free survival in advanced breast cancer
EurekAlert! - 8 Oct 2016 06:00
(European Society for Medical Oncology) The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves progression-free survival in postmenopausal women with hormone receptor-positive advance...
Immunotherapy: Promising results in first & second line treatment of metastatic bladder cancer
EurekAlert! - 8 Oct 2016 06:00
(European Society for Medical Oncology) Immunotherapy has shown promising results in first and second line treatment of metastatic bladder cancer in two phase II trials presented at the ESMO 2016 Congress in Copenhagen.
Targeting estrogen receptor improves progression-free survival in advanced breast cancer
EurekAlert! - 8 Oct 2016 06:00
(European Society for Medical Oncology) Fulvestrant significantly increases progression-free survival in women with hormone-receptor-positive advanced breast cancer, particularly those with less aggressive lower-volume d...
Ipilimumab as adjuvant therapy improves overall survival in high risk stage III melanoma
EurekAlert! - 8 Oct 2016 06:00
(European Society for Medical Oncology) Ipilimumab as adjuvant therapy significantly improves overall survival in patients with high risk stage III melanoma, according to the EORTC 18071 phase III trial results presented...
Niraparib significantly improves outcome of ovarian cancer patients in landmark trial
EurekAlert! - 8 Oct 2016 06:00
(European Society for Medical Oncology) The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for ...
Phase I study of novel anti-cancer drug uses tumor mRNA expression to identify responders
EurekAlert! - 8 Oct 2016 06:00
(European Society for Medical Oncology) The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metasta...